News
Drug and biotech news
Trade press headlines, FDA announcements, new drug and biologic approvals, and Class I recalls, newest first. Refreshed hourly. Stories open on the publisher's site.
Last checked: Nov 20, 2026Source: BioPharma Dive, STAT (pharma), FDA press releases, FDA MedWatch, Drugs@FDA (new approvals), openFDA (Class I recalls)
All areasOncologyHematology and blood cancersCardiovascular and metabolicNeurologyPsychiatryImmunology and inflammationInfectious disease and vaccinesRespiratoryRare and genetic diseaseKidney and urologyGastroenterology and liverEndocrinology and women's healthOphthalmologyDermatologyPain and anesthesia
1 stories
Tagged Gastroenterology and liver from the headline and teaser, so some stories may be missed or misfiled.
- Trade pressSTAT (pharma)Nov 20, 2026STAT+: Early results for Alterome's KRAS drug for pancreas, lung and colon cancer arrive
Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of cancers in the pancreas, lung and colon:
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.